Skip to main content
S 2952 117th Congress Senate Health

FDA Modernization Act of 2021

Introduced: October 7, 2021 Introduced by: Paul, Rand Republican · Kentucky See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 7, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct 7, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

FDA Modernization Act of 2021

This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, computer modeling, and other human biology-based test methods.

What's happening now October 7, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
  • HR 7667 Related bill Food and Drug Amendments of 2022
  • S 4348 Related bill FDASLA Act of 2022
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 6

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2026
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 1st Quarter (Jan 1 - Mar 31) 2026
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 4th Quarter (Oct 1 - Dec 31) 2025
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 3rd Quarter (July 1 - Sep 30) 2025
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2025
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 1st Quarter (Jan 1 - Mar 31) 2025
 Cosponsors 13
All 13 Democratic 5 Republican 6 Independent 2
R
Scott, Rick
Florida · Nov 14, 2022
 D
Kaine, Tim
Virginia · Sep 19, 2022
 R
Crapo, Mike
Idaho · Sep 14, 2022
 R
Marshall, Roger
Kansas · Sep 8, 2022
 R
Lee, Mike
Utah · Aug 1, 2022
 I
Sanders, Bernard
Vermont · Jun 6, 2022
 D
Whitehouse, Sheldon
Rhode Island · May 4, 2022
 I
King, Angus S., Jr.
Maine · Mar 22, 2022
 D
Padilla, Alex
California · Mar 1, 2022
 R
Collins, Susan M.
Maine · Oct 18, 2021
 D
Booker, Cory A.
New Jersey · Oct 7, 2021
 R
Kennedy, John
Louisiana · Oct 7, 2021
 D
Luján, Ben Ray
New Mexico · Oct 7, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2952: FDA Modernization Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2952/
MLA
"S. 2952: FDA Modernization Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2952/.
Bluebook (legal)
S. 2952, 117th Cong. (2026), https://openamerica.io/bill/117-S-2952/.
Markdown link
[S. 2952: FDA Modernization Act of 2021](https://openamerica.io/bill/117-S-2952/)
Report a problem